Structure	Catalog	Product Name	CAS	E3 Ligase	Target	Inquiry
	BPL-201673	4-((17-(4-(((1-(6-Amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)-1H-1,2,3-triazol-1-yl)-3,6,9,12,15-pentaoxaheptadecyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione	2624181-70-8	CRBN	SHP2	Inquiry
Molecular Weight: 952.88 Molecular Formula: C44H55Cl2N11O9 Density: 1.47±0.1 g/cm3 Description: It is a CRBN-recruiting PROTAC molecule targeting SHP2 by connecting pomalidomide with SHP099, an allosteric inhibitor of SHP2.
	BPL-201674	4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)ethoxy)ethoxy)acetamido)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide	2648294-70-4	CRBN	HDAC1 HDAC2 HDAC3 HDAC6	Inquiry
Molecular Weight: 738.75 Molecular Formula: C35H42N6O12 Density: 1.384±0.06 g/cm3 Description: It is a proteolysis-targeting chimera (PROTAC), which efficiently degrades histone deacetylases.
	BPL-201675	HD-TAC1		CRBN	HDAC3	Inquiry
Molecular Weight: 639.67 Molecular Formula: C33H33N7O7 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201676	HD-TAC2		CRBN	HDAC3	Inquiry
Molecular Weight: 582.62 Molecular Formula: C31H30N6O6 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201677	HD-TAC3		CRBN	HDAC2	Inquiry
Molecular Weight: 596.64 Molecular Formula: C32H32N6O6 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201678	HD-TAC4		CRBN	HDAC3	Inquiry
Molecular Weight: 568.59 Molecular Formula: C30H28N6O6 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201679	HD-TAC5		CRBN	HDAC2 HDAC3	Inquiry
Molecular Weight: 653.70 Molecular Formula: C34H35N7O7 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 2 and 3 (HDAC2 and HDAC3).
	BPL-201680	HD-TAC6		CRBN	HDAC3	Inquiry
Molecular Weight: 625.64 Molecular Formula: C32H31N7O7 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201681	HD-TAC7		CRBN	HDAC3	Inquiry
Molecular Weight: 657.66 Molecular Formula: C33H32FN7O7 Description: It is a proteolysis targeting chimera (PROTAC) that induces protein degradation of histone deacetylase 3 (HDAC3).
	BPL-201682	A001	2756586-39-5	CRBN	AR	Inquiry
Molecular Weight: 849.43 Molecular Formula: C47H53ClN6O7 Boiling Point: 996.5±65.0°C at 760 Torr Density: 1.37±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201683	A002	2756586-40-8	CRBN	AR	Inquiry
Molecular Weight: 848.45 Molecular Formula: C47H54ClN7O6 Boiling Point: 1013.8±65.0°C at 760 Torr Density: 1.37±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201684	A003	2756586-41-9	CRBN	AR	Inquiry
Molecular Weight: 834.42 Molecular Formula: C46H52ClN7O6 Boiling Point: 1009.9±65.0°C at 760 Torr Density: 1.38±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201685	A004	2756586-42-0	CRBN	AR	Inquiry
Molecular Weight: 820.39 Molecular Formula: C45H50ClN7O6 Boiling Point: 1005.6±65.0°C at 760 Torr Density: 1.40±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201686	A005	2756586-43-1	CRBN	AR	Inquiry
Molecular Weight: 780.29 Molecular Formula: C40H42ClN9O6 Density: 1.49±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201687	A006	2756586-44-2	CRBN	AR	Inquiry
Molecular Weight: 766.26 Molecular Formula: C39H40ClN9O6 Density: 1.51±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201688	A007	2756586-45-3	CRBN	AR	Inquiry
Molecular Weight: 794.31 Molecular Formula: C41H44ClN9O6 Density: 1.47±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201689	A008	2756586-46-4	CRBN	AR	Inquiry
Molecular Weight: 808.34 Molecular Formula: C42H46ClN9O6 Density: 1.45±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201690	A009	2756586-47-5	CRBN	AR	Inquiry
Molecular Weight: 822.37 Molecular Formula: C43H48ClN9O6 Density: 1.43±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201691	A010	2756586-48-6	CRBN	AR	Inquiry
Molecular Weight: 808.34 Molecular Formula: C42H46ClN9O6 Density: 1.45±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.
	BPL-201692	A011	2756586-49-7	CRBN	AR	Inquiry
Molecular Weight: 794.31 Molecular Formula: C41H44ClN9O6 Density: 1.47±0.1 g/cm3 Description: It is an effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer.

PROTAC Library